Clinical trial
A New Neuroregulatory Technology for the Therapy of AN Based on the Pathological Neural Network of ACC: A Multicenter Randomized Controlled Study
NCT06152640 is registered in ClinicalTrials.gov with Shanghai Mental Health Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A New Neuroregulatory Technology for the Therapy of AN Based on the Pathological Neural Network of ACC: A Multicenter Randomized Controlled Study
- Lead sponsor
- Shanghai Mental Health Center
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 30, 2024
- Completion date
- May 31, 2026
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.